International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
A clear cell carcinoma of the colorectum is a rare oncologic entity and, thus, the clinical and imaging features of such have not been adequately investigated. Thus far, only 13 cases have been documented in the English literature, according to the results of searches using PubMed. The majority of reported primary colonic clear cell adenocarcinomas are located in the left colon and are more common in elderly men (1–2). Clinical and imaging features have not been adequately investigated due to its rarity. Considerable diagnostic difficulties may arise when distinguishing primary colonic clear cell adenocarcinoma and metastatic carcinomas from sites such as the kidney and testis (3). In the majority of cases colonic clear cell adenocarcinomas are treated by a polypectomy or segmental resection. Clinical data regarding tumor-associated mortality and disease-free survival in patients with primary clear cell adenocarcinoma of the colorectum is limited. In this study, a new case of clear cell adenocarcinoma of the colon in a 26-year-old male is presented. The aim of this study was to investigate the clinical and computed tomography (CT) features of the neoplasm. Written informed consent was obtained from the patient’s family.
A 26-year-old male was admitted to Yantai Yuhuangding Hospital (Yantai, China) with a palpable abdominal mass, which had gradually increased in size for three months. The patient had no history of abdominal pain, melena, body weight loss or change in bowel habits. Standard blood tests and chest X-rays revealed no abnormalities. Ultrasound of the abdomen showed no abnormal findings from the liver and gall bladder, pancreas, testes and genital tract or kidneys. General examination was negative, with the exception of an extensive, immobile mass (13 cm in diameter) in the left upper quadrant of the abdomen.
CT examination of the abdomen was performed prior to and following the administration of an intravenous contrast agent. Sagittal and coronal reformatted images were obtained. Abdominal CT revealed an ill-defined mass (12×10 cm in size) located in the left upper quadrant. On unenhanced images the mass was hypo-attenuated in relation to the liver (Fig. 1). The mass exhibited heterogeneous moderate enhancement following contrast material administration. The mass encased the left part of the transverse colon, displaced the loop of small bowel inferiorly and the pancreas superiorly, and invaded the spleen (Figs. 2–4). No signs of bowel obstruction were identified. The CT observations indicated a malignant tumor, possibly of colonic origin. The patient underwent subsequent colonoscopy, which revealed a stenotic tumor mass in the transverse colon close to the spleen flexure (Fig. 5).
During surgery, an extensive mass, measuring 12 cm maximally, was found arising from the transverse colon close to the left colonic flexure, with invasion of the spleen. The tumor was exophytic, with a lobulated and irregular surface. The cross section revealed transmural invasion. The tumor and the spleen were resected concurrently.
Histological examination of the resected specimen revealed a tumor entirely composed of polygonal and oval cells arranged in lobules, which were separated by fibrous septa containing chronic inflammatory cells. The cells had abundant cytoplasm, which varied from clear to eosinophilic. The nuclei included one or more prominent vesicular and pleomorphic nucleoli (Fig. 6). Immunohistochemical staining revealed that the cells were positive for cytokeratin and epithelial membrane antigen, and negative for vimentin and HMB45. Based on the morphological and immunohistochemical observations, clear cell adenocarcinoma of the colon was diagnosed.
The patient improved and was discharged 10 days following surgery. However, one and a half years following surgery, the tumor recurred in the peritoneal cavity, at the site of the left colonic flexure. The patient succumbed to the disease three years following surgery.
Clear cell adenocarcinomas are well characterized in the kidneys (4), lower urinary tract (5), ovaries (6), extraovarian endometriosis (7) and female genital tract (8). These organs originate from the mullerian system, which may explain the occurrence of clear cell adenocarcinoma in these systems (9). However, clear cell adenocarcinoma of the colorectum is rare. Thus far, only 13 such cases have been reported in the English literature. Therefore, this tumor type is considered to be a rare malignancy and its ontogeny remains unclear; however, certain clear cell adenocarcinomas form part of a larger conventional adenoma or situate next to an adenoma (2,3), thus supporting the theory that the adenoma-carcinoma sequence of colorectal carcinogenesis is also valid for clear cell adenocarcinoma.
Regarding the clinical characteristics, more male patients exhibiting clear cell adenocarcinoma of the colorectum have been reported, and the tumor tends to be located on the left side (2), which is consistent with the present case. However, the young age (27 years) of the patient in the present case is noteworthy. Clear cell adenocarcinomas generally affect elderly males with an average age of 62 years (1).
In contrast to previous studies, the patient in the current case presented with a palpable abdominal mass without exhibiting any symptoms that indicated colonic adenocarcinoma, including melena, a change in bowel habits or symptoms of bowel obstruction. This may be associated with the exophytic growth pattern of the tumor. Due to the absence of specific clinical manifestations, the tumor was not identified until it had enlarged enough to be palpated. This condition is uncommon for a primary colonic adenocarcinoma.
On CT imaging, the present tumor appeared as an extensive extracolic mass in the left upper quadrant, which encased the left part of the transverse colon, displaced the loop of small bowel and the pancreas, and invaded the spleen. It was difficult to identify the origin of the mass due to its large size and prominent extraluminal location. However, the tumor site and its association with the transverse colon may provide an indication.
Noteworthy considerations in the differential diagnosis of primary clear cell adenocarcinoma of the colon are metastases from other organs, including the kidneys, lower urinary tract, ovaries and female genital tract. The majority of reported cases of clear cell adenocarcinoma in the colon have been identified later as metastases originating from renal clear cell malignancies, which may occur 16 years following resection (10). In the present case, the patient had no history or evidence of tumors elsewhere, on clinical and imaging examination, which indicated its primary origin at this site. Furthermore, the present tumor lacked the hypervascularity usually observed in renal clear cell carcinoma, thus favoring the diagnosis of a primary colonic clear cell carcinoma. Differential diagnosis with other colonic tumors appears to be difficult based on the preoperative imaging; however, the patient’s clinical characteristics and the predominantly extraluminal growth pattern of the tumor may provide useful information. Further reports are required for the elucidation of this tumor.
Clinical data regarding tumor-associated mortality and disease-free survival in patients with primary clear cell adenocarcinoma of the colorectum is rare, as a result of the short-term follow up and small number of cases. Previous studies have indicated that the behavior of this tumor is not significantly different from that of conventional intestinal carcinomas; however, further studies are required to investigate this.
In conclusion, in this study, a rare case of clear cell adenocarcinoma of the colon in a young male was presented. The case was reported due to rarity, and the clinical and computed tomography features were analyzed. The tumor presented as an extensive extracolic mass, which is uncommon for a primary colonic tumor. The predominantly extraluminal growth pattern exhibited by the tumor, as well as the patient’s clinical characteristics, may be key features of advanced colonic clear cell adenocarcinoma.